Skip to main content

Select Drug Profiles

Helping Patients Cope with Agitation: The Role of Pharmacists and Payers

Jeffrey D. Dunn, PharmD, MBA

Aligning Proactive Agitation Management in Clinical Settings

Grant D. Lawless, RPh, MD, FACP

Epidemiologic Assessments of Abuse-Deterrent Formulations

Sabby Muneer, PhD

Abuse-Deterrent Formulations: An Early Epidemiologic Appraisal

Ofer M. Wellisch, MD, MPH

Are We Winning the War on Drugs?

Atheer A. Kaddis, PharmD

Assessing Abuse-Deterrent Formulations: Much Work Still Remains

Gary M. Owens, MD

In Vitro and Clinical Assessments of Abuse-Deterrent Formulations for Chronic Pain

Sabby Muneer, PhD

Clinical Assessment of Abuse-Deterrent Formulations

Ofer M. Wellisch, MD, MPH

The Tip of the Iceberg

Atheer A. Kaddis, PharmD

In Vitro and Clinical Assessments of Abuse-Deterrent Formulations in the Management of Chronic Pain

Gary M. Owens, MD

Page 121 of 244
Results 1201 - 1210 of 2438